Back to Search
Start Over
357P Bridging the gap between real-world studies (RWSs) and randomized controlled trials (RCTs) of 1st-line palbociclib+aromatase inhibitors (P+AI) in hormone receptor-positive (HR+)/HER2-negative(-) metastatic breast cancer (mBC).
- Source :
-
Annals of Oncology . 2024 Supplement 2, Vol. 35, pS366-S367. 2p. - Publication Year :
- 2024
- Subjects :
- *METASTATIC breast cancer
*HORMONES
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 179691715
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.08.305